Almirall
FDA Approved Drugs

Almirall

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX Discontinued
  • Total Records 15
  • Latest Approval Date Dec 14, 2020
  • Data Source FDA
  • First Approval Date Jan 01, 1982
All
15
View
Discontinued
2
View
RX
13
View
Company Overview

Company

Almirall

Country

Spain

Email

Social Profiles

LinkedIn
Company Snapshot

Almirall

Ronda General Mitre, 151 08022 Barcelona

Spain

www.almirall.com/ View on Map
FDA Approved Drug Records ( 15 records )
2005
07 Jul
RX Application: 21794

Drug Name

ACZONE

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

2005-07-07

21794 / 1

Active Ingredient

DAPSONE

Application Number

21794

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

2005-07-07

Regulatory Status

RX

2016
24 Feb
RX Application: 207154

Drug Name

ACZONE

Product Number

1

Dosage Form

-

Strength

7.5%

Approval Date

2016-02-24

207154 / 1

Active Ingredient

DAPSONE

Application Number

207154

Product Number

1

Dosage Form

-

Strength

7.5%

Approval Date

2016-02-24

Regulatory Status

RX

2007
12 Apr
Discontinued Application: 22055

Drug Name

ALTABAX

Product Number

1

Dosage Form

-

Strength

1%

Approval Date

2007-04-12

22055 / 1

Active Ingredient

RETAPAMULIN

Application Number

22055

Product Number

1

Dosage Form

-

Strength

1%

Approval Date

2007-04-12

Regulatory Status

Discontinued

2002
30 Sep
RX Application: 21184

Drug Name

AVAGE

Product Number

3

Dosage Form

-

Strength

0.1%

Approval Date

2002-09-30

21184 / 3

Active Ingredient

TAZAROTENE

Application Number

21184

Product Number

3

Dosage Form

-

Strength

0.1%

Approval Date

2002-09-30

Regulatory Status

RX

1995
13 Sep
RX Application: 20428

Drug Name

AZELEX

Product Number

1

Dosage Form

-

Strength

20%

Approval Date

1995-09-13

20428 / 1

Active Ingredient

AZELAIC ACID

Application Number

20428

Product Number

1

Dosage Form

-

Strength

20%

Approval Date

1995-09-13

Regulatory Status

RX

1982
01 Jan
RX Application: 16455

Drug Name

CORDRAN

Product Number

1

Dosage Form

-

Strength

0.004MG/SQ CM

Approval Date

1982-01-01

16455 / 1

Active Ingredient

FLURANDRENOLIDE

Application Number

16455

Product Number

1

Dosage Form

-

Strength

0.004MG/SQ CM

Approval Date

1982-01-01

Regulatory Status

RX

2020
14 Dec
RX Application: 213189

Drug Name

KLISYRI

Product Number

1

Dosage Form

-

Strength

1%

Approval Date

2020-12-14

213189 / 1

Active Ingredient

TIRBANIBULIN

Application Number

213189

Product Number

1

Dosage Form

-

Strength

1%

Approval Date

2020-12-14

Regulatory Status

RX

2018
01 Oct
RX Application: 209521

Drug Name

SEYSARA

Product Number

1

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

2018-10-01

209521 / 1

Active Ingredient

SARECYCLINE HYDROCHLORIDE

Application Number

209521

Product Number

1

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

2018-10-01

Regulatory Status

RX

2018
01 Oct
RX Application: 209521

Drug Name

SEYSARA

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2018-10-01

209521 / 2

Active Ingredient

SARECYCLINE HYDROCHLORIDE

Application Number

209521

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2018-10-01

Regulatory Status

RX

2018
01 Oct
RX Application: 209521

Drug Name

SEYSARA

Product Number

3

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-10-01

209521 / 3

Active Ingredient

SARECYCLINE HYDROCHLORIDE

Application Number

209521

Product Number

3

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-10-01

Regulatory Status

RX

1999
10 Dec
Discontinued Application: 20922

Drug Name

SOLAGE

Product Number

1

Dosage Form

-

Strength

2%;0.01%

Approval Date

1999-12-10

20922 / 1

Active Ingredient

MEQUINOL; TRETINOIN

Application Number

20922

Product Number

1

Dosage Form

-

Strength

2%;0.01%

Approval Date

1999-12-10

Regulatory Status

Discontinued

1997
13 Jun
RX Application: 20600

Drug Name

TAZORAC

Product Number

1

Dosage Form

-

Strength

0.05%

Approval Date

1997-06-13

20600 / 1

Active Ingredient

TAZAROTENE

Application Number

20600

Product Number

1

Dosage Form

-

Strength

0.05%

Approval Date

1997-06-13

Regulatory Status

RX

1997
13 Jun
RX Application: 20600

Drug Name

TAZORAC

Product Number

2

Dosage Form

-

Strength

0.1%

Approval Date

1997-06-13

20600 / 2

Active Ingredient

TAZAROTENE

Application Number

20600

Product Number

2

Dosage Form

-

Strength

0.1%

Approval Date

1997-06-13

Regulatory Status

RX

2000
29 Sep
RX Application: 21184

Drug Name

TAZORAC

Product Number

1

Dosage Form

-

Strength

0.05%

Approval Date

2000-09-29

21184 / 1

Active Ingredient

TAZAROTENE

Application Number

21184

Product Number

1

Dosage Form

-

Strength

0.05%

Approval Date

2000-09-29

Regulatory Status

RX

2000
29 Sep
RX Application: 21184

Drug Name

TAZORAC

Product Number

2

Dosage Form

-

Strength

0.1%

Approval Date

2000-09-29

21184 / 2

Active Ingredient

TAZAROTENE

Application Number

21184

Product Number

2

Dosage Form

-

Strength

0.1%

Approval Date

2000-09-29

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    3 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    15 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
15 total
  • RX
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ACZONE

Application Number

21794

Product Number

1

Active Ingredient

DAPSONE

Dosage Form

-

Strength

5%

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.